MENU
MDGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Madrigal Pharmaceuticals (MDGL) Ownership - Who owns Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
200 Barr Harbor Drive
Phone
+1 267 824-2827
Employees
276
Web
http://www.madrigalpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.82B
P/E Ratio
N/A
Total Cash
926.25M
Projected Growth
N/A
Total Debt
119.57M
Revenue
180.13M
Risk (Beta)
-1.05
Dividend Yield
N/A
Total Cash/Share
41.95
Total Debt/Equity
N/A
Revenue/Share
8.47 USD as % of share price
Fundamentals
MDGL
Capitalization
6.82B
P/E Ratio
N/A
Risk (Beta)
-1.05
Dividend Yield
N/A
Total Cash
926M
Total Cash/Share
41.95
Total Debt
120M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
8.47%
Revenue
180M
ROE
N/A
Book Value
754M
P/B Ratio
8.86
Cash Flow
N/A
Earnings
-21.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
6.10
Current Revenue Per Employee
195681.81
Dividends Per Share - Security
N/A
EBITDA
-450.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.67
Revenue To Assets
-55.37
Shares Held By Institutions
12.1B
Shares Outstanding - Current
22.1M
Total Liabilities
288M
Total Volume MTD
N/A
Value
-1
Gain YTD
0.071
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
200 Barr Harbor Drive
Phone
+1 267 824-2827
Employees
276
Web
http://www.madrigalpharma.com